United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Publisher Name :
Date: 22-Nov-2016
No. of pages: 95
Inquire Before Buying

Notes:

Sales, means the sales volume of 23-Valent Pneumococcal Polysaccharide Vaccine

Revenue, means the sales value of 23-Valent Pneumococcal Polysaccharide Vaccine

This report studies sales (consumption) of 23-Valent Pneumococcal Polysaccharide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- MSD

- Sanofipasteur

- CDIBP

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Single Dose Vial

- Pre-filled Syringe

- Type III

Split by applications, this report focuses on sales, market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in each application, can be divided into

- For Children (2-10)

- For Person (10-64)

- For The old (=65)

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Table of Contents
United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016
1 23-Valent Pneumococcal Polysaccharide Vaccine Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.2.3 Type III
1.3 Application of 23-Valent Pneumococcal Polysaccharide Vaccine
1.3.1 For Children (2-10)
1.3.2 For Person (10-64)
1.3.3 For The old (=65)
1.4 United States Market Size Sales (Value) and Revenue (Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2011-2021)
1.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Competition by Manufacturers
2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) by Application (2011-2016)
4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Profiles/Analysis
5.1 MSD
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sanofipasteur
5.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 CDIBP
5.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
6.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2016-2021)
10.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2016-2021)
10.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2016-2021)
10.4 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2015
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Table Application of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2015
Figure For Children (2-10) Examples
Figure For Person (10-64) Examples
Figure For The old (=65) Examples
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Figure 2016 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2016 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers in 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Table MSD Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Sanofipasteur Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table CDIBP Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Forecast by Type (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)
    Published: 25-May-2017        Price: US 2000 Onwards        Pages: 164
    Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., G......
  • 2017 Top 5 Avian Influenza Vaccines Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 19-May-2017        Price: US 4960 Onwards        Pages: 157
    "This report will be delivered in 2-3 business days after the order is placed." The Global Avian Influenza Vaccines market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Avian Influenza Vaccines in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Avian Influenza V......
  • 2017-2022 China Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis - FAT......
  • 2017-2022 Global Top Countries Avian Influenza Vaccines Market Report
    Published: 19-May-2017        Price: US 4960 Onwards        Pages: 157
    "This report will be delivered in 2-3 business days after the order is placed." The Global Avian Influenza Vaccines market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Avian Influenza Vaccines in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Aus......
  • 2017-2022 India Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis - FAT......
  • 2017-2022 Japan Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis - FAT......
  • 2017-2022 Malaysia Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis ......
  • 2017-2022 Philippines Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Philippines market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis......
  • 2017-2022 United States Avian Influenza Vaccines Market Report (Status and Outlook)
    Published: 19-May-2017        Price: US 3360 Onwards        Pages: 116
    "This report will be delivered in 2-3 business days after the order is placed." The Avian Influenza Vaccines market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs